S.M.Kirov Military Medical Academy, 6 Academician Lebedev str., St. Petersburg 194044, Russian Federation, e-mail:
Saint-Petersburg Medical-Social Institute, 72A Kondratyevsky pr., St. Petersburg 195271, Russian Federation.
Adv Gerontol. 2023;36(2):251-255.
Temporomandibular arthralgia is difficult to treat, painful and often relapses. 48 patients (19 men and 29 women) aged 61-72 years, suffering from the syndrome of pain dysfunction of the temporomandibular joint, were under observation. In 1st (control) group of patients (18 people), NSAIDs indomethacin in tablet form of 25 mg 3 times a day were used for 9 days. In patients of the 2nd (main) group (30 people), the method of invasive carboxytherapy was used, consisting in subcutaneous injection of carbon dioxide with a volume of 3 ml of 5 procedures every other day. On the 3rd, 9th and 15th days of follow-up, invasive carboxytherapy was more effective than the use of a nonsteroidal anti-inflammatory agent by 8.9; 36,5 and 37%, respectively. The high efficiency of the method of invasive carboxytherapy for the elimination of pain symptoms in pain dysfunction was shown, which was 22,86% on day 3; 64,29% on day 9 and 68,16% on day 15 of observation. The method of invasive carboxytherapy can be used in the complex treatment of patients with pain dysfunction of the temporomandibular joint.
颞下颌关节痛治疗困难，疼痛且常复发。观察了 48 名 61-72 岁的颞下颌关节疼痛功能障碍综合征患者（19 男 29 女）。在第 1 组（对照组）患者（18 人）中，每天口服 25mg 吲哚美辛片 3 次，共 9 天。在第 2 组（主要组）患者（30 人）中，采用侵入性二氧化碳疗法，每隔一天皮下注射 3 毫升二氧化碳共 5 次。在第 3、9 和 15 天的随访中，侵入性二氧化碳疗法的效果优于非甾体抗炎药，分别为 8.9；36.5 和 37%。该方法显示出对疼痛功能障碍消除疼痛症状的高效性，在第 3 天为 22.86%；第 9 天为 64.29%，第 15 天为 68.16%。侵入性二氧化碳疗法可用于颞下颌关节疼痛功能障碍患者的综合治疗。
